Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans.

Mar 24 2024Quibim It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets.

The platform features a post-processing solution for fat and iron quantification that performs fully automatic analyses of abdominal MRI examinations containing multi-echo chemical shift sequences that can precisely detect and quantify fat content. It can then generate parametric maps of fat and iron, offering detailed analysis by processing each tiny 3D element of the scan individually to generate what is known as voxel-wise resolution.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Overeating and starving both damage the liver: Cavefish provide new insight into fatty liver diseaseFatty liver, which can lead to liver damage and disease, can occur from both overeating and starvation. Now, new research shows how naturally starvation-resistant cavefish, unlike other animals, are able to protect their liver and remain healthy. The findings have implications for understanding and potentially addressing liver conditions in humans.
Source: medical_xpress - 🏆 101. / 51 Read more »

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancerFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein. Scientists at St.
Source: medical_xpress - 🏆 101. / 51 Read more »

Immune evasion tactics of liver cancer cells revealedA faulty cancer gene helps tumors evade immunity by stopping tumor cells releasing message-containing cargoes called exosomes.
Source: medical_xpress - 🏆 101. / 51 Read more »

Experts help bring first-of-its-kind drug for metabolic liver disease to the clinicLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD).
Source: medical_xpress - 🏆 101. / 51 Read more »

Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver diseaseScience China Life Sciences has reported on the research results of Lanjuan Li's team from Zhejiang University. Recent advances in microbiome research have revealed complex changes in gut microecology across various disease states, highlighting their profound impact on disease progression.
Source: medical_xpress - 🏆 101. / 51 Read more »